Searched for
MULTINATIONAL PHARMA COMPANIES
Lupin partner Sandoz launches RanluspecTM across Europe for retinal disease treatmentLupin Ltd has partnered with Sandoz to launch RanluspecTM, a biosimilar for Ranibizumab, across Europe. This launch will help to improve ac...- India may open doors to multinational pharma firms for first-in-human Phase I trialsIndia is considering modifications to its pharmaceutical regulatory framework to attract multinational companies for clinical trials. Discu...
- Over 1,300 anti-cancer drugs to get cheaperIndia's National Pharmaceutical Pricing Authority is set to cap trade margins on anti-cancer drugs starting November 2026. The initiative a...
- These mid-caps have ‘strong buy’ & ‘buy’ recos and upside potential of up to 28%, according to analystsGlobal markets on Wednesday celebrated the outcome of the US mid-term election as well as a sharp drop in oil prices. Oil prices, which at ...
- Wockhardt seeks 14-year data shield for India-made drugsMumbai-based Wockhardt has struck success in its innovative research on a range of antibiotic drugs, bridging a global pipeline gap for dif...
- Mold-Tek Packaging shares surge 17% as Q2 FY 27 profit jumps 35% YoY to Rs 21 croreMold-Tek Packaging shares surged nearly 17% after the company reported a 35.5% YoY rise in Q2 FY27 net profit and 30.5% revenue growth. Str...
- Sanofi healthcare receives CDSCO approval for Qftilia therapy for haemophilia patients in IndiaSanofi Healthcare has obtained authorisation from the Central Drugs Standard Control Organisation for Qfitlia. This therapy is designed to ...
- NATCO Pharma subsidiary launches Carboplatin in US market to address shortagesIndian pharmaceutical company NATCO Pharma annouced the launch of Carboplatin Injection, a generic version of Paraplatin in the US market b...
- The burden of cancer drugs: Millions battle exorbitant prices as life-saving treatment slips out of reachFor millions of cancer patients, the cost of treatment can be as frightening as the diagnosis. From steep markups to patented drugs that re...
- Danish brewing giant Carlsberg’s India arm, 3 others get Sebi nod to float IPOsIn a significant move for India's market, Sebi has greenlit IPOs for Carlsberg's local entity, TMC Transformers, Ujin Pharma, and Matangi R...
- Where Does China Fit in Your Company’s Innovation Strategy?For decades, multinationals treated China primarily as either a vast growth market or a rising competitive threat. But as growth slows, com...
- Drug cos against move to rationalise trade margins on patented productsThe representatives of Organisation of Pharmaceutical Producers of India (OPPI), which represents multinational pharma companies and domest...
- Amit Rajan on why pharma MNCs are beating Indian counterpartsPatent protection, ban on fixed dose combinations among factors helping pharma MNCs
- UP to open 6 pharma parks; gets Rs 5,000-6,000 cr commitmentThe UP government is planning to open six pharma parks across the state and has received an investment commitment of about Rs 5,000-6,000 c...
- Dilip Shanghvi, second-wealthiest Indian, is the poorest pharma CEOShanghvi’s salary for 2013-14 was Rs 2.73 crore, according to data sifted by ET from filings of leading listed drug companies.
- India eyes $40 billion global generic market; patents held by MNCs to expire in over 3 yearsAnalysts say the timing to promote Indian generics globally is just right as the next three years will be crucial in terms of opportunity.
- GSK Pharma: Investors must be careful of the competitive threats it faces in IndiaWhile the company's performance in the June quarter was strong sequentially, it will be interesting to see GSK's strategies to overcome the...
- FDI curbs in pharma could deter MNCs: Kewal Handa, Pfizer India MDIndia's attempts to check foreign investment in pharma and expand drug pricing control could force multinationals to exit the country.
- Ipca, Indoco Remedies attractive in pharma space: Sudip BandyopadhyayCompanies like Ipca and Indoco Remedies are very attractively priced today.
- Let pharma takeovers beSale of Indian drug companies to multinationals is a way of value creation for Indian entrepreneurs and investors.
Load More
